Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 16 de 16 
Presentar resultados
Seleccionar todas
1.Tiene citas relacionadas
Collins R, Reith C, Emberson J, Armitage J, Baigent C, Blackwell L, Blumenthal R, Danesh J, Smith GD, Demets D, Evans S, Law M, McMahon S, Martin S, Neal B, Poulter N, Preiss D, Ridker P, Roberts I, Rodgers A, Sandercok P, Schulz K, Sever P, Simes J, Smeeth L, Wald N, Yusuf S, Peto R. Interpretation of the evidence for the efficacy and safety of statin therapy. Lancet 2016;388:2532-61. [Ref.ID 100988]
2.Tiene citas relacionadas Cita con resumen
Brighton TA, Eikelboom JW, Simes J. Aspirin for preventing venous thromboembolism. Author/editor response. N Engl J Med 2013;368:773. [Ref.ID 94967]
3.Tiene citas relacionadas Cita con resumen
Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J, for the ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012;367:1979-87. [Ref.ID 94109]
4.Tiene citas relacionadas
Kearney PM, Keech A, Simes J, Collins R, Baigent C, on behalf of the Cholesterol Treatment Trialists' (CTT) Collaboration. Statins and diabetes. Authors' reply. Lancet 2008;371:1752. [Ref.ID 82975]
5. Cita con resumen
Timmer JR, Ottervanger JP, De Boer MJ, Boersma E, Grines CL, Westerhout CM, Simes J, Granger CB, Zijlstra F, for the Primary Coronary Angioplasty vs Thrombolysis - 2 Trialists Collaborators Group. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus. Arch Intern Med 2007;167:1353-9. [Ref.ID 80630]
6.Tiene citas relacionadas Cita con resumen
Keech A, Simes J, Barter P, Best J, Scott R, Taskinen MR, on behalf of the FIELD Management Committee. Correction to the FIELD study report. Lancet 2006;368:1415. [Ref.ID 78331]
7.Tiene citas relacionadas Cita con resumen
Baigent C, Keech A, Kearney P, Collins R, Simes J, on behalf of the Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of cholesterol-lowering treatment. Authors' reply. Lancet 2006;367:470-1. [Ref.ID 76163]
8. Cita con resumen
Boersma E, Harrington RA, Moliterno DJ, White H, Théroux P, Van de Werf F, de Torbal A, Armstrong PW, Wallentin LC, Wilcox RG, Simes J, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002;359:189-98. [Ref.ID 61023]
9. Cita con resumen
Hunt D, Young P, Simes J, Hague W, Mann S, Owensby D, Lane G, Tonkin A, for the LIPID Investigators. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial. Ann Intern Med 2001;134:931-40. [Ref.ID 56739]
10. Cita con resumen
Shakespeare TP, Gebski VJ, Veness MJ, Simes J. Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours. Lancet 2001;357:1349-53. [Ref.ID 56431]
11.Tiene citas relacionadas
Tonkin A, Colquhoun D, Simes J, White H, Hunt D, for the LIPID Study Group. Pravastatin and coronary heart disease. Lancet 2001;357:1040. [Ref.ID 55806]
12. Cita con resumen
White HD, Simes J, Anderson NE, Hankey GJ, Watson JDG, Hunt D, Colquhoun M, Glasziou P, MacMahon S, Kirby AC, West MJ, Tonkin AM. Pravastatin therapy and the risk of stroke. N Engl J Med 2000;343:317-26. [Ref.ID 52299]
13.Tiene citas relacionadas Cita con resumen
Weaver WD, Simes J, Betriu A, Grines CL, Zijlstra F, García E, Grinfeld L, Gibbons RJ, Ribeiro E E, DeWood MA, Ribichini F. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. A quantitative review. JAMA 1997;278:2093-8. [Ref.ID 36212]
14. Cita con resumen
Mark DB, Hlatky MA, Califf RM, Naylor C D, Lee K L, Armstrong PW, Barbash G, White H, Simoons ML, Nelson C L, Clapp-Channing N, Knight JD, Harrell FE, Simes J, Topol EJ. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418-24. [Ref.ID 27237]
15.
Van de Werf F, Topol EJ, Lee K L, Woodlief LH, Granger CB, Armstrong PW, Barbash GI, Hampton JR, Guerci A, Simes J, Ross A M, Califf RM, for the GUSTO Investigators. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. JAMA 1995;273:1586-91. [Ref.ID 24220]
16.
Lee K L, Califf RM, Simes J, Van de Werf F, Topol EJ, for the GUSTO Investigators. Holding GUSTO up to the light. Ann Intern Med 1994;120:876-81. [Ref.ID 21928]
Seleccionar todas
 
 1 a 16 de 16